Entera Bio (ENTX) Stock Price, Quote, News & History | Benzinga

Entera Bio Ltd (ENTX) Stock Price, Quote, News & History

ENTXNASDAQ

Trade with Public

Trade with Public

$2.92

0.020.69%

At close: Sep 2, 5:00 PM EST

$2.86

-0.06-2.05%

After Hours: Sep 1, 5:39 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$2.90

Close

$2.92

Volume / Avg.

143.50K / 2.51M

Day Range

$2.84 - $3.00

52 Wk Range

0.91 - 4.20

Market Cap

$495.19M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

51

Short Interest

0.57%

Days to Cover

1.92

Recent Entera Bio Ltd News

Entera Bio Rebounds As Investors Balance Phase 3 Funding Against Dilution Risk

Entera Bio financing lifts ENTX as investors weigh a $275 million cash boost, EB613 funding and dilution risk.

Akanksha Bakshi

Crude Oil Falls Sharply; US Durable Goods Orders Increase 0.3% In June

US stocks mixed in midday trading, Nasdaq falls 0.48%, Dow up 0.19%, S&P 500 down 0.23%. Consumer staples up 2%, tech down 1.9%. Durable goods orders rise 0.3%.

Avi Kapoor

Dow Jumps Over 400 Points; AstraZeneca Shares Rise After Q2 Earnings

Dow Jones up 0.80% to 52,361.92, NASDAQ up 0.23% to 25,024.65, S&P 500 up 0.28% to 7,432.59. Communication services up 2.5%, energy down 1.84%.

Avi Kapoor

Stock Market Today: S&P 500, Dow, Nasdaq Futures Gain As Trump Calls Iran's New Leaders 'Very Reasonable'— PLTR, RZLV, ENTX In Focus (UPDATED)

Editor’s Note: The future prices of benchmark tracking ETFs and the headline were updated in the story. U.S. stock futures rose on Monday following Friday’s sharp sell-off. Futures of the major benchmark indices were higher after they entered the correction territory last week, falling more than 10% below their 52-week highs.

Rishabh Mishra

Phreesia, Progress Software And 3 Stocks To Watch Heading Into Monday

U.S. stock futures up, focus on quarterly earnings of Americas Gold and Silver, ARKO Petroleum, Entera Bio, Phreesia, and Progress Software.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-10.89M

Investing Cash Flow (TTM)

-73.00K

Financing Cash Flow (TTM)

10.51M

Free Cash Flow (TTM)

-10.96M

Capital Expenditure (TTM)

-73.00K

Net Change in Cash (TTM)

-413.00K

Analyst Trends and Forecast

1

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$490.36M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

68.99

Earnings Yield % (TTM)

-12.09%

Earnings Yield % (FWD)

-19.69%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.04

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$11.31M

Debt to Equity

0.06

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$2.90

Close

$2.92

Volume / Avg.

143.50K / 2.51M

Day Range

$2.84 - $3.00

52 Wk Range

0.91 - 4.20

Market Cap

$495.19M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

51

Short Interest

0.57%

Days to Cover

1.92

About

Sector

Health Care

Industry

Biotechnology

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where ...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Entera Bio (ENTX) stock?

A

You can purchase shares of Entera Bio (NASDAQ:ENTX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Entera Bio (ENTX) competitors?

A

Other companies in Entera Bio’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Entera Bio (ENTX) stock?

A

Entera Bio has a consensus price target of $9.00.

Q

What is the current price for Entera Bio (ENTX)?

A

The stock price for Entera Bio (NASDAQ: ENTX) is $2.86 last updated September 1, 2026 at 5:39 PM EDT.

Q

Does Entera Bio (ENTX) pay a dividend?

A

There are no upcoming dividends for Entera Bio.

Q

When is Entera Bio (NASDAQ:ENTX) reporting earnings?

A

Entera Bio does not have any upcoming earnings scheduled.

Q

Is Entera Bio (ENTX) going to split?

A

There is no upcoming split for Entera Bio.

Q

What sector and industry does Entera Bio (ENTX) operate in?

A

Entera Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.